Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online Thursday calling the shots. Earnings news flow continued to taper.
Biopharma companies working on vaccines/therapies for COVID-19 continued to provide updates. Novavax, Inc. (NASDAQ:NVAX) shares more than doubled, thanks to an announcement concerning a $384 million grant from the Coalition for Epidemic Preparedness Innovations.
Here are the key catalysts for the unfolding week.
Conferences
- UBS Virtual Global Healthcare Conference: May 18-20
- RBC Capital Markets 2020 Global Healthcare Virtual Conference: May 19-20
- European Society for Medical Oncology, or ESMO, Breast Cancer Virtual Meeting: May 23-24
PDUFA Dates
The FDA is due to rule on Aquestive Therapeutics Inc's (NASDAQ:AQST) NDA for apomorphine sublingual film (APL-130277), which is being evaluated for treating off episodes in Parkinson's disease patients. APL-130277 is being developed by Sunovion Pharmaceuticals, a subsidiary of Sumitomo Dainippon Pharma, in partnership with Aquestive.
Clinical Readouts
Entera Bio Ltd (NASDAQ:ENTX) is scheduled to report on Thursday interim three-month top-line biomarker data for the first 50% of the patients enrolled in the Phase 2 osteoporosis clinical trial of EB613.
Oncolytics Biotech, Inc. (NASDAQ:ONCY) is due to present at the ESMO Breast Cancer Conference, interim biomarker data from the AWARE-1 early-stage breast cancer study that is evaluating its pelareorep along with Roche Holdings AG's (OTC:RHHBY) Tecentriq.
Earnings
Monday
Milestone Scientific Inc. (NYSE:MLSS) (before the market open)
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) (after the close)
Tuesday
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (after the close)
Ascendis Pharma A/S (NASDAQ:ASND) (after the close)
Wednesday
Mediwound Ltd (NASDAQ:MDWD) (before the market open)
China Biologic Products Holdings Inc (NASDAQ:CBPO) (after the close)
Thursday
Entera Bio (before the market open)
Medtronic PLC (NYSE:MDT) (before the market open)
PAVmed Inc (NASDAQ:PAVM) (after the close)
Xenon Pharmaceuticals Inc (NASDAQ:XENE) (after the close)
IPO Quiet Period Expiry
ORIC Pharmaceuticals Inc (NASDAQ:ORIC)
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.